TIme to make some changes... To bad the self regulating organization is not interested in making the playing field level and fair. If they did you would find out that many of the high flying hedge funds and HFT are not as good as their past records indicated.
You know that is not true so why post garbage like this? Just to get attention like a little kid? You can read post after post about all the phase 2 drugs in the pipeline. The speculation of when a partner will sign up and take on one or all of these block buster drugs.... You can read or look at our balance sheet and see we will be needing cash next year. Everyone knows the cash flow generated from Belviq is not that much and so far this year Eisai is not doing anything big, new and exciting with marketing...
It will be one of those partnerships that will inject a large amount of cash into Arena or as I suspect, we will get a big buy out at that point...
So no our prospects are not highly dependent on the success of Belviq and you know it.
Create FEAR? Are you kidding me watching my stock to to .60 is an enormous amount of pain !!!! You don't think there is already a tremendous amount of fear out there already? All out hopes are on the Phase 3 and based on Phase 2 it should do very well. But the proof in the pudding as they say is the Phase 3 studies...
No FUD here, just was not expecting GALE to crush me like my Arena did... Don't hold many bio tech stocks but they all are creating a lot of pain these days......
New CEO is a start but they need to replace John Tattery and many of the BOD that allowed the destruction of DSCO under their watch and care, or lack there of.
32.44 million shares went to 270, same equivalent move in GALEs 181.67 million shares would be 48.21
BOD need to be let go as well, they allowed the miss management for years from Cooper and the previous CEO as well.
I thought that as well, but dropping this much after the raise seems excessive and unwarranted unless we have bigger issues.... Yes I know all about bear raids and short attacks. But keep in mind to short a stock under 2 bucks you need to have 2.50 equity for every share to short. Not a great return on equity. Seems like there are better places to harvest sell stops and bear raid.
Belviq is a great drug, I know many that have lost a lot of weight. Go onto the Belviq support group on facebook or belsuccess web page. The drug works even better then the studies indicated. The only flop or failure was Eisais ability to launch a new and novel drug into a huge market that has some left over baggage from past failures...
If they want to find a place to lay blame, they should start by looking in the mirror. I could list a ton of mis steps and last minute reactionary decisions that were made, aka, knee jerk reactions... The truth shall set you free.
Nope, the last PR out from the company was the second of 2 partnerships announced in 6 months.
January 13, 2016 4:25 PM
Arena Pharmaceuticals, Inc. ARNA and Boehringer Ingelheim announced the signing of an exclusive agreement under which the companies will jointly conduct research to identify drug candidates targeting an undisclosed G protein-coupled receptor (GPCR), part of the group of orphan central nervous system (CNS) receptors.
Who needs accuracy when you have the internet. HaHa
Never thought it would go so low.... However, with the Bio Tech sell off or CRASH maybe it was just overdone.
being complied and has been leaked and is not as good as hoped for?
Just a question, not a bash.
That makes no sense. Selling off assets you paid dearly for to make the company more attractive to a buyer? Seriously? Assets are Assets...
I think they sold off the assets to reserve cash for the pipeline and that is exactly what was stated.
Qsymia = The combination of the drugs phen and topiramate extended-release is a medication used for weight loss.
Contrave= It combines bupropion and naltrexone. Both drugs have individually shown some evidence of effectiveness in weight loss, and the combination is expected to have a synergistic effect.[
I already responded to a similar re post. But look at the date and go back and look at what analysts were projecting in Belviq sales. I was not the only investor looking for Belviq to be a success. We were growing scripts at a much faster rate then VVUS.. Funny thing is I was bashed because I posted much slower script growth then the board wanted to see at the time. And in hind sight, my numbers were way to high as well. Eisai was marketing was abysmal and they could not even maintain a 2-3% week over week growth rate.
I mean with 400 reps some times we saw script gains of 200 for a week or less not even on script per sales rep per week growth... Sad..
I was wrong. But I have already state I was wrong on several occasions..
But I did not foresee management increasing expenses by 50% going from 80 million to 130+ million per year. I did however, believe the growth curve was going to be a lot lower then LC and Jack lief was saying. I was saying 2 years to get to a fraction of the numbers that LC and Jack were projecting...
At the time break even scripting levels were something like 24,000 scripts per week. But again never dreamed Eisai would be such a poor marketing partner. And was furious when we chose to sell them the entire world for a fraction of its value since they were proving to be so poor a marketing partner...
But thanks for bringing it up... jerky
Wow, it closed at 258.53
Higher open, higher low, higher high and higher close.... Bounce mode...
You will reap what you are sowing here.. When you are questioning God and asking why ?
Just remember all of the nastiness, lying and ill will towards others you have been spewing on these boards.